FRASCHINI, FRANCO LUIGI

FRASCHINI, FRANCO LUIGI  

DIPARTIMENTO DI FARMACOLOGIA, CHEMIOTERAPIA E TOSSICOLOGIA MEDICA (attivo dal 01/01/1960 al 26/04/2012)  

Mostra records
Risultati 1 - 20 di 78 (tempo di esecuzione: 0.007 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 2015 E. PalazzoF. FraschiniA. BediniG. Tarzia + Article (author) -
Melatonin reduces the need for sedation in ICU patients : a randomized controlled trial 2015 G. MistralettiM. UmbrelloG. SabbatiniS. MioriM. TavernaP. FormentiA. D'AgostinoS. SaliniA. MorabitoFRASCHINI, FRANCO LUIGIG. Iapichino + Article (author) -
Melatonin reduces the need for sedation in ICU patients: A randomized controlled trial 2015 Mistraletti G.Umbrello M.Sabbatini G.Miori S.Taverna M.Mantovani E. S.Formenti P.Spanu P.D'Agostino A.Salini S.Morabito A.Fraschini F.Iapichino G. + Article (author) -
Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain 2015 F. Fraschini + Article (author) -
Antitumour activity of melatonin in a mouse model of human prostate cancer : relationship with hypoxia signalling 2014 R. ParoniL. TerraneoE. FinatiE. VirgiliP. BianciardiG. FaveroF. FraschiniM. Samaja + Article (author) -
Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease 2013 F. Fraschini + Article (author) -
Melatonin : positive effects on high-risk patients with desynchronized sleep-wake rhythm 2013 E. FinatiG. MistralettiG. IapichinoF. FraschiniR. Paroni Article (author) -
Pharmacokinetics of oral melatonin in high-risk critically ill : standard formulation vs incapsulation in solid lipid nanoparticles (SLN) 2012 G. MistralettiE. MantovaniR.C. ParoniE. FinatiF.L. FraschiniG. Iapichino + Conference Object -
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765 : Comparison with melatonin and diazepam 2012 F. Fraschini + Article (author) -
Symptomatic Spinal Degenerative Pathologies: Clinical Results with the Application of Conservative Biochemical Treatments 2012 F. Fraschini + Article (author) -
Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT2 Melatonin Receptor Ligand 2011 F. Fraschini + Article (author) -
Erratum: The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells (European Journal of Pharmacology (2010) 641 (29-34)) 2011 Dozio E.Ruscica M.Passafaro L.Dogliotti G.Steffani L.Marthyn P.Demartini G.Esposti D.Fraschini F.Magni P. + Article (author) -
LNCaP Prostate Cancer Growth In Vivo : Oncostatic Effects of Melatonin as compared to Hypoxia and Reoxygenation 2011 L. TerraneoE. FinatiE. VirgiliG. DemartiniL. De AngelisF.L. FraschiniM. SamajaR.C. Paroni + Book Part (author) -
Effetti clinici della melatonina nei pazienti critici ad alto rischio 2011 G. MistralettiS. MioriG. SabbatiniS. SaliniA. MorabitoF.L. FraschiniG. Iapichino + Conference Object -
La melatonina riduce la necessità di sedativi e di analgesici in pazienti critici ad alto rischio 2011 G. MistralettiM. TavernaMIORI, SARAS. SaliniA. MorabitoF.L. FraschiniG. Iapichino + Conference Object -
Treatment of symptomatic lumbar spinal degenerative pathologies by means of combined conservative biochemical treatments 2011 F. Fraschini + Book Part (author) -
Pharmacokinetics of orally administered melatonin in critically ill patients 2010 G. MistralettiG. SabbatiniM. TavernaM.A. FiginiM. UmbrelloP. MagniM. RuscicaE. DozioR. EspostiG. DemartiniF. FraschiniG. Iapichino + Article (author) -
The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells 2010 E. DozioM. RuscicaL. PassafaroG. DogliottiG. DemartiniD. EspostiF. FraschiniP. Magni + Article (author) -
Melatonin delivery in solid lipid nanoparticles : prevention of cyclosporine A induced cardiac damage 2009 F. FraschiniG. Demartini + Article (author) -
The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimer's disease 2007 F. Fraschini + Article (author) -